Skip to content
Open access

Integrated Computational Strategies for identifying Potential Drug Candidates against Spinal Tuberculosis

Sep 2026 · Research journal of biotechnology · 0 citations

Abstract

Drug resistance against various diseases including tuberculosis (TB) is an unfortunate reality of humankind. Total drug resistance (TDR) against TB has been a major cause of increasing cases throughout the world. Moreover, finding a new drug is more challenging against such a disease. Herein, we have selected a drug target SLC11A1 (Solute carrier 11 protein), which is a divalent cation transporter and is crucial for uptake of important ions in the bacterial cytosol. The targeting of SLC11A1 through novel inhibitors gives us a putative edge in the direction of drug designing against TB. Therefore, we have screened a library of bioactive compounds from a commercial database and identified a few of them based on virtual screening scores and their interactions with the potential binding site. Further, these compounds were investigated using Molecular dynamics (MD) simulations for their binding stability. Our findings suggest that repurposed FDA-approved drugs may serve as viable candidates for combating drug-resistant tuberculosis, warranting further experimental validation.

Read PDF

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.